Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Opperman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Microbiology|May 28, 2016
Optimization of a novel series of pyranopyridine RND efflux pump inhibitorsZachary Aron, Timothy J Opperman
Research in Microbiology|November 18, 2017
The hydrophobic trap-the Achilles heel of RND efflux pumpsZachary Aron, Timothy J Opperman
Current Protocols in Pharmacology|February 2, 2012
Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discoverySteven M Kwasny, Timothy J Opperman
Frontiers in Microbiology|May 23, 2015
Recent advances toward a molecular mechanism of efflux pump inhibitionTimothy J Opperman, Son T Nguyen
ACS Infectious Diseases|November 18, 2023
Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in <i>Pseudomonas aeruginosa</i> Using Split LuciferaseHanling Guo, Emily J Geddes, Timothy J Opperman, et al.
Current Opinion in Pharmacology|July 31, 2012
New classes of antibioticsDonald T Moir, Timothy J Opperman, Michelle M Butler, et al.
Drug Discovery Today|April 12, 2021
Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitorsDonald T Moir, Timothy J Opperman, Zachary D Aron, et al.
Antimicrobial Agents and Chemotherapy|August 13, 2014
Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitorsAttilio V Vargiu, Paolo Ruggerone, Timothy J Opperman, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
In vitro potency and in vivo efficacy of a novel bis-indole antimicrobial compound in reducing catheter colonizationMohammad D Mansouri, Timothy J Opperman, John D Williams, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small MoleculesTimothy J Opperman, Sourabh Dhingra, Cecilia Gutierrez-Perez, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Microbiology|May 28, 2016
Optimization of a novel series of pyranopyridine RND efflux pump inhibitorsZachary Aron, Timothy J Opperman
Research in Microbiology|November 18, 2017
The hydrophobic trap-the Achilles heel of RND efflux pumpsZachary Aron, Timothy J Opperman
Current Protocols in Pharmacology|February 2, 2012
Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discoverySteven M Kwasny, Timothy J Opperman
Frontiers in Microbiology|May 23, 2015
Recent advances toward a molecular mechanism of efflux pump inhibitionTimothy J Opperman, Son T Nguyen
ACS Infectious Diseases|November 18, 2023
Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in <i>Pseudomonas aeruginosa</i> Using Split LuciferaseHanling Guo, Emily J Geddes, Timothy J Opperman, et al.
Current Opinion in Pharmacology|July 31, 2012
New classes of antibioticsDonald T Moir, Timothy J Opperman, Michelle M Butler, et al.
Drug Discovery Today|April 12, 2021
Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitorsDonald T Moir, Timothy J Opperman, Zachary D Aron, et al.
Antimicrobial Agents and Chemotherapy|August 13, 2014
Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitorsAttilio V Vargiu, Paolo Ruggerone, Timothy J Opperman, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
In vitro potency and in vivo efficacy of a novel bis-indole antimicrobial compound in reducing catheter colonizationMohammad D Mansouri, Timothy J Opperman, John D Williams, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small MoleculesTimothy J Opperman, Sourabh Dhingra, Cecilia Gutierrez-Perez, et al.
Pageof 4